John G. Frelinger - Publications

School of Medicine and Dentistry University of Rochester, Rochester, NY 
Immunology, Microbiology Biology, Cell Biology

78 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Bottaro A, Brown DM, Frelinger JG. Editorial: The Present and Future of Immunology Education. Frontiers in Immunology. 12: 744090. PMID 34408756 DOI: 10.3389/fimmu.2021.744090  1
2019 Haidaris CG, Frelinger JG. Inoculating a New Generation: Immunology in Medical Education. Frontiers in Immunology. 10: 2548. PMID 31749807 DOI: 10.3389/Fimmu.2019.02548  0.01
2019 Skrombolas D, Sullivan M, Frelinger JG. Development of an Interleukin-12 Fusion Protein That Is Activated by Cleavage with Matrix Metalloproteinase 9. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. PMID 30848689 DOI: 10.1089/Jir.2018.0129  1
2016 Mikucki ME, Skitzki JJ, Frelinger JG, Odunsi K, Gajewski TF, Luster AD, Evans SS. Unlocking tumor vascular barriers with CXCR3: Implications for cancer immunotherapy. Oncoimmunology. 5: e1116675. PMID 27467928 DOI: 10.1080/2162402X.2015.1116675  1
2016 Mikucki ME, Skitzki JJ, Frelinger JG, Odunsi K, Gajewski TF, Luster AD, Evans SS. Unlocking tumor vascular barriers with CXCR3: Implications for cancer immunotherapy Oncoimmunology. DOI: 10.1080/2162402X.2015.1116675  1
2015 Mikucki ME, Fisher DT, Matsuzaki J, Skitzki JJ, Gaulin NB, Muhitch JB, Ku AW, Frelinger JG, Odunsi K, Gajewski TF, Luster AD, Evans SS. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nature Communications. 6: 7458. PMID 26109379 DOI: 10.1038/Ncomms8458  1
2015 Skrombolas D, Wylie I, Maharaj S, Frelinger JG. Characterization of an IL-12 p40/p35 Truncated Fusion Protein That can Inhibit the Action of IL-12. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 35: 690-7. PMID 25938719 DOI: 10.1089/Jir.2014.0176  1
2014 Skrombolas D, Frelinger JG. Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy. Expert Review of Clinical Immunology. 10: 207-17. PMID 24410537 DOI: 10.1586/1744666X.2014.875856  1
2013 Sedlacek AL, Gerber SA, Randall TD, van Rooijen N, Frelinger JG, Lord EM. Generation of a dual-functioning antitumor immune response in the peritoneal cavity. The American Journal of Pathology. 183: 1318-28. PMID 23933065 DOI: 10.1016/J.Ajpath.2013.06.030  1
2013 Yokota SJ, Facciponte JG, Kelleher RJ, Shultz LD, Loyall JL, Parsons RR, Odunsi K, Frelinger JG, Lord EM, Gerber SA, Balu-Iyer SV, Bankert RB. Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft model. Cancer Immunity. 13: 11. PMID 23885217  1
2013 Gerber SA, Sedlacek AL, Cron KR, Murphy SP, Frelinger JG, Lord EM. IFN-γ mediates the antitumor effects of radiation therapy in a murine colon tumor. The American Journal of Pathology. 182: 2345-54. PMID 23583648 DOI: 10.1016/J.Ajpath.2013.02.041  1
2013 Gerber SA, Sorensen EW, Sedlacek AL, Lim JY, Skrombolas D, Frelinger JG, Lord EM. Local expression of interleukin-2 by B16 melanoma cells results in decreased tumour growth and long-term tumour dormancy. Immunology. 138: 280-92. PMID 23198850 DOI: 10.1111/Imm.12037  1
2011 Valentino MD, Abdul-Alim CS, Maben ZJ, Skrombolas D, Hensley LL, Kawula TH, Dziejman M, Lord EM, Frelinger JA, Frelinger JG. A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens. Journal of Immunological Methods. 373: 111-26. PMID 21872603 DOI: 10.1016/J.Jim.2011.08.007  1
2011 Puskas J, Skrombolas D, Sedlacek A, Lord E, Sullivan M, Frelinger J. Development of an attenuated interleukin-2 fusion protein that can be activated by tumour-expressed proteases. Immunology. 133: 206-20. PMID 21426339 DOI: 10.1111/J.1365-2567.2011.03428.X  1
2011 Valentino MD, Maben ZJ, Hensley LL, Woolard MD, Kawula TH, Frelinger JA, Frelinger JG. Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets. Immunology. 132: 348-60. PMID 21214540 DOI: 10.1111/J.1365-2567.2010.03387.X  1
2010 Sorensen EW, Gerber SA, Frelinger JG, Lord EM. IL-12 suppresses vascular endothelial growth factor receptor 3 expression on tumor vessels by two distinct IFN-gamma-dependent mechanisms. Journal of Immunology (Baltimore, Md. : 1950). 184: 1858-66. PMID 20061409 DOI: 10.4049/Jimmunol.0903210  1
2009 Valentino MD, Hensley LL, Skrombolas D, McPherson PL, Woolard MD, Kawula TH, Frelinger JA, Frelinger JG. Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS. Molecular Immunology. 46: 1830-8. PMID 19233475 DOI: 10.1016/J.Molimm.2009.01.008  1
2009 Valentino M, Frelinger J. An approach to the identification of T cell epitopes in the genomic era: Application to Francisella tularensis Immunologic Research. 45: 218-228. PMID 19212707 DOI: 10.1007/S12026-009-8103-Z  1
2008 Lugade AA, Sorensen EW, Gerber SA, Moran JP, Frelinger JG, Lord EM. Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity. Journal of Immunology (Baltimore, Md. : 1950). 180: 3132-9. PMID 18292536 DOI: 10.4049/Jimmunol.180.5.3132  1
2007 Santos K, Simon DA, Conway E, Bowers WJ, Mitra S, Foster TH, Lugade A, Lord EM, Federoff HJ, Dewhurst S, Frelinger JG. Spatial and temporal expression of herpes simplex virus type 1 amplicon-encoded genes: implications for their use as immunization vectors. Human Gene Therapy. 18: 93-105. PMID 17298238 DOI: 10.1089/Hum.2006.082  1
2007 Malboeuf CM, Simon DA, Lee YE, Lankes HA, Dewhurst S, Frelinger JG, Rose RC. Human papillomavirus-like particles mediate functional delivery of plasmid DNA to antigen presenting cells in vivo. Vaccine. 25: 3270-6. PMID 17293010 DOI: 10.1016/J.Vaccine.2007.01.067  1
2007 Ramanayake T, Simon DA, Frelinger JG, Lord EM, Robert J. In vivo study of T-cell responses to skin alloantigens in Xenopus using a novel whole-mount immunohistology method. Transplantation. 83: 159-66. PMID 17264812 DOI: 10.1097/01.Tp.0000250562.35175.06  1
2007 Santos K, Duke CM, Rodriguez-Colon SM, Dakwar A, Fan S, Keefer MC, Federoff HJ, Frelinger JG, Bowers WJ, Dewhurst S. Effect of promoter strength on protein expression and immunogenicity of an HSV-1 amplicon vector encoding HIV-1 Gag. Vaccine. 25: 1634-46. PMID 17145123 DOI: 10.1016/J.Vaccine.2006.11.004  1
2006 Mitra S, Cassar SE, Niles DJ, Puskas JA, Frelinger JG, Foster TH. Photodynamic therapy mediates the oxygen-independent activation of hypoxia-inducible factor 1alpha. Molecular Cancer Therapeutics. 5: 3268-74. PMID 17172430 DOI: 10.1158/1535-7163.Mct-06-0421  1
2006 Gerber SA, Rybalko VY, Bigelow CE, Lugade AA, Foster TH, Frelinger JG, Lord EM. Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. The American Journal of Pathology. 169: 1739-52. PMID 17071597 DOI: 10.2353/Ajpath.2006.051222  1
2006 Wagner VE, Frelinger JG, Barth RK, Iglewski BH. Quorum sensing: dynamic response of Pseudomonas aeruginosa to external signals. Trends in Microbiology. 14: 55-8. PMID 16406629 DOI: 10.1016/J.Tim.2005.12.002  1
2005 Lugade AA, Moran JP, Gerber SA, Rose RC, Frelinger JG, Lord EM. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. Journal of Immunology (Baltimore, Md. : 1950). 174: 7516-23. PMID 15944250 DOI: 10.4049/Jimmunol.174.12.7516  1
2005 Gerber SA, Turner MJ, Lugade AA, Moran JP, Frelinger JG, Lord EM. Characterization of a lymph node within the mouse prostate: Detailed analysis using whole mount histology. The Prostate. 63: 105-16. PMID 15468173 DOI: 10.1002/Pros.20169  1
2004 Bigelow CE, Vishwasrao HD, Frelinger JG, Foster TH. Imaging enzyme activity with polarization-sensitive confocal fluorescence microscopy. Journal of Microscopy. 215: 24-33. PMID 15230872 DOI: 10.1111/J.0022-2720.2004.01357.X  1
2004 Bigelow CE, Frelinger JG, Foster TH. Enzyme activity imaging with confocal fluorescence polarization microscopy Biosilico. DOI: 10.1364/Bio.2004.Fh14  1
2003 Mitra S, Goren EM, Frelinger JG, Foster TH. Activation of heat shock protein 70 promoter with meso-tetrahydroxyphenyl chlorin photodynamic therapy reported by green fluorescent protein in vitro and in vivo. Photochemistry and Photobiology. 78: 615-22. PMID 14743872 DOI: 10.1562/0031-8655(2003)078<0615:Aohspp>2.0.Co;2  1
2003 Moran JP, Gerber SA, Martin CA, Frelinger JG, Lord EM. Transfection of the genes for interleukin-12 into the K1735 melanoma and the EMT6 mammary sarcoma murine cell lines reveals distinct mechanisms of antitumor activity. International Journal of Cancer. Journal International Du Cancer. 106: 690-8. PMID 12866028 DOI: 10.1002/Ijc.11284  1
2003 Gerber SA, Moran JP, Frelinger JG, Frelinger JA, Fenton BM, Lord EM. Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts. British Journal of Cancer. 88: 1453-61. PMID 12778077 DOI: 10.1038/Sj.Bjc.6600907  1
2002 Fisher TL, Nocera M, Willis RA, Turner MJ, Abdul Alim CS, Brown DM, Bourne PA, di Sant'Agnese PA, Messing EM, Lord EM, Frelinger JG. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors. The Prostate. 51: 153-65. PMID 11967950 DOI: 10.1002/Pros.10071  1
2001 Patel D, Frelinger J, Goudsmit J, Kim B. In vitro assay for site-specific proteases using bead-attached GFP substrate. Biotechniques. 31: 1194, 1196, 1198 pas. PMID 11730026 DOI: 10.2144/01315Dd04  1
2001 Skrincosky D, Willis RA, Hocknell PK, Frelinger JG, Mirandola P, Wang X, Dewhurst S. Epitope mapping of human herpesvirus-7 gp65 using monoclonal antibodies. Archives of Virology. 146: 1705-22. PMID 11699957 DOI: 10.1007/S007050170058  1
2001 Willis RA, Bowers WJ, Turner MJ, Fisher TL, Abdul-Alim CS, Howard DF, Federoff HJ, Lord EM, Frelinger JG. Dendritic cells transduced with HSV-1 amplicons expressing prostate-specific antigen generate antitumor immunity in mice. Human Gene Therapy. 12: 1867-79. PMID 11589829 DOI: 10.1089/104303401753153929  1
2001 Turner MJ, Abdul-Alim CS, Willis RA, Fisher TL, Lord EM, Frelinger JG. T-cell antigen discovery (T-CAD) assay: a novel technique for identifying T cell epitopes. Journal of Immunological Methods. 256: 107-19. PMID 11516759 DOI: 10.1016/S0022-1759(01)00436-7  1
2001 Brown DM, Fisher TL, Wei C, Frelinger JG, Lord EM. Tumours can act as adjuvants for humoral immunity. Immunology. 102: 486-97. PMID 11328383 DOI: 10.1046/J.1365-2567.2001.01213.X  1
2000 Egan RM, Yorkey C, Black R, Loh WK, Stevens JL, Storozynsky E, Lord EM, Frelinger JG, Woodward JG. In vivo behavior of peptide-specific T cells during mucosal tolerance induction: antigen introduced through the mucosa of the conjunctiva elicits prolonged antigen-specific T cell priming followed by anergy. Journal of Immunology (Baltimore, Md. : 1950). 164: 4543-50. PMID 10779755 DOI: 10.4049/Jimmunol.164.9.4543  1
2000 Lee J, Moran JP, Fenton BM, Koch CJ, Frelinger JG, Keng PC, Lord EM. Alteration of tumour response to radiation by interleukin-2 gene transfer British Journal of Cancer. 82: 937-944. PMID 10732769 DOI: 10.1054/Bjoc.1999.1022  1
2000 Conway TF, Sabel MS, Sugano M, Frelinger JG, Egilmez NK, Chen FA, Bankert RB. Growth of human tumor xenografts in SCID mice quantified using an immunoassay for tumor marker protein in serum Journal of Immunological Methods. 233: 57-65. PMID 10648856 DOI: 10.1016/S0022-1759(99)00190-8  1
1999 Storozynsky E, Woodward JG, Frelinger JG, Lord EM. Interleukin-3 and granulocyte-macrophage colony-stimulating factor enhance the generation and function of dendritic cells Immunology. 97: 138-149. PMID 10447725 DOI: 10.1046/J.1365-2567.1999.00741.X  1
1998 Ostberg JR, Barth RK, Frelinger JG. The Roman god Janus: A paradigm for the function of CD43 Immunology Today. 19: 546-550. PMID 9864944 DOI: 10.1016/S0167-5699(98)01343-7  1
1998 Wei C, Callahan BP, Turner MJ, Willis RA, Lord EM, Barth RK, Frelinger JG. Regulation of human prostate-specific antigen gene expression in transgenic mice: evidence for an enhancer between the PSA and human glandular kallikrein-1 genes. International Journal of Molecular Medicine. 2: 487-96. PMID 9857240 DOI: 10.3892/Ijmm.2.4.487  1
1998 Willis RA, Wei C, Turner MJ, Callahan BP, Pugh AE, Barth RK, Lord EM, Frelinger JG. A transgenic strategy for analyzing the regulatory regions of the human prostate-specific antigen gene: potential applications for the treatment of prostate cancer (Review). International Journal of Molecular Medicine. 1: 379-86. PMID 9852240 DOI: 10.3892/Ijmm.1.2.379  1
1998 Lord EM, Yeh KY, Moran JA, Storozynsky E, Frelinger JG. IL-3-mediated enhancement of particulate antigen presentation by macrophages. Journal of Immunotherapy (Hagerstown, Md. : 1997). 21: 205-10. PMID 9610912 DOI: 10.1097/00002371-199805000-00006  1
1998 Lord EM, Frelinger JG. Tumor immunotherapy: Cytokines and antigen presentation Cancer Immunology Immunotherapy. 46: 75-81. PMID 9558002 DOI: 10.1007/S002620050464  1
1997 Ostberg JR, Dragone LL, Borrello MA, Phipps RP, Barth RK, Frelinger JG. Expression of mouse CD43 in the B cell lineage of transgenic mice causes impaired immune responses to T-independent antigens. European Journal of Immunology. 27: 2152-9. PMID 9341753 DOI: 10.1002/Eji.1830270906  1
1997 McEvoy LM, Sun H, Frelinger JG, Butcher EC. Anti-CD43 inhibition of T cell homing. The Journal of Experimental Medicine. 185: 1493-8. PMID 9126930 DOI: 10.1084/Jem.185.8.1493  1
1996 Pulaski BA, Yeh KY, Shastri N, Maltby KM, Penney DP, Lord EM, Frelinger JG. Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells Proceedings of the National Academy of Sciences of the United States of America. 93: 3669-3674. PMID 8622994 DOI: 10.1073/Pnas.93.8.3669  1
1995 Dragone LL, Barth RK, Sitar KL, Disbrow GL, Frelinger JG. Disregulation of leukosialin (CD43, Ly48, sialophorin) expression in the B-cell lineage of transgenic mice increases splenic B-cell number and survival Proceedings of the National Academy of Sciences of the United States of America. 92: 626-630. PMID 7831340 DOI: 10.1073/Pnas.92.2.626  1
1995 McAdam AJ, Pulaski BA, Harkins SS, Hutter EK, Lord EM, Frelinger JG. Synergistic effects of co-expression of the TH1 cytokines IL-2 and IFN-gamma on generation of murine tumor-reactive cytotoxic cells. International Journal of Cancer. 61: 628-34. PMID 7768635 DOI: 10.1002/Ijc.2910610508  1
1994 McAdam AJ, Felcher A, Woods ML, Pulaski BA, Hutter EK, Frelinger JG, Lord EM. Transfection of transforming growth factor-beta producing tumor EMT6 with interleukin-2 elicits tumor rejection and tumor reactive cytotoxic T-lymphocytes. Journal of Immunotherapy With Emphasis On Tumor Immunology : Official Journal of the Society For Biological Therapy. 15: 155-64. PMID 8032538 DOI: 10.1097/00002371-199404000-00001  1
1993 McAdam A, Pulaski B, Harkins S, Hutter E, Frelinger J, Lord E. Coexpression of IL-2 and γ-IFN enhances tumor immunity Annals of the New York Academy of Sciences. 690: 349-351. PMID 8368753 DOI: 10.1111/J.1749-6632.1993.Tb44027.X  1
1993 Lord E, McAdam A, Felcher A, Woods M, Pulaski B, Hutter E, Frelinger J. Transfection of TGF-β producing tumors with IL-2 elicits tumor rejection Annals of the New York Academy of Sciences. 690: 346-348. PMID 8368752 DOI: 10.1111/J.1749-6632.1993.Tb44026.X  1
1993 McAdam AJ, Yeh KY, Pulaski BA, Frelinger JG, Lord EM. Interleukin-3 inhibits the generation of nonspecific killers by interleukin-2 Journal of Immunotherapy. 14: 293-297. PMID 8280711 DOI: 10.1097/00002371-199311000-00007  1
1993 Gaspari AA, Ferbel B, Frelinger JG. Thy 1+ dendritic epidermal cells but not langerhans cells express Ly 48 Journal of Investigative Dermatology. 100: 247-253. PMID 8095056 DOI: 10.1111/1523-1747.Ep12469016  1
1992 McAdam AJ, Blieden TM, Frelinger JG, Lord EM. CD4-class II major histocompatibility complex interaction does not enhance killing by a class I-restricted CD4+CD8+ cytotoxic T cell clone European Journal of Immunology. 22: 2461-2464. PMID 1516633 DOI: 10.1002/Eji.1830220942  1
1990 Dorfman KS, Litaker W, Baecher CM, Frelinger JG. The nucleotide sequence of Ly 48 (mouse leukosialin, sialophorin): The mouse homolog of CD43 Nucleic Acids Research. 18: 4932. PMID 2144340 DOI: 10.1093/Nar/18.16.4932  1
1990 Pallant A, Fukuda M, Frelinger JG. CD43 (leukosialin, sialophorin, large sialoglycoprotein) can be expressed in both normal and Wiskott-Aldrich fibroblasts via transfection of a leukosialin cDNA European Journal of Immunology. 20: 1423-1428. PMID 2143724 DOI: 10.1002/Eji.1830200703  1
1990 Baecher CM, Dorfman KS, Mattei MG, Frelinger JG. cDNA cloning and localization of the mouse leukosialin gene (Ly48) to chromosome 7 Immunogenetics. 31: 307-314. PMID 1973410 DOI: 10.1007/Bf02115004  1
1988 Baecher CM, Infante AJ, Semcheski KL, Frelinger JG. Identification and characterization of a mouse cell surface antigen with alternative molecular forms Immunogenetics. 28: 295-302. PMID 3169878 DOI: 10.1007/Bf00364226  1
1987 Bahler DW, Frelinger JG, Harwell LW, Lord EM. Reduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection Proceedings of the National Academy of Sciences of the United States of America. 84: 4562-4566. PMID 3496596 DOI: 10.1073/Pnas.84.13.4562  1
1985 Frelinger JG, Shigeta M, Fathman CG. An analysis of monoclonal T cell and antibody recognition sites on Ia molecules Journal of Investigative Dermatology. 85. PMID 3874247 DOI: 10.1111/1523-1747.Ep12275430  1
1984 Frelinger JG, Shigeta M, Infante AJ, Nelson PA, Pierres M, Fathman CG. Multiple functional sites on a single Ia molecule defined using T cell clones and antibodies with chain-determined specificity. The Journal of Experimental Medicine. 159: 704-15. PMID 6421980 DOI: 10.1084/Jem.159.3.704  1
1984 Frelinger J, Sing A, Infante A, Fathman CG. Clonotypic antibodies which stimulate T cell clone proliferation Immunological Reviews. 21-38. PMID 6334643 DOI: 10.1111/J.1600-065X.1984.Tb01103.X  1
1983 Fathman CG, Frelinger JG. T-lymphocyte clones Annual Review of Immunology. 1: 633-655. PMID 6242467 DOI: 10.1146/Annurev.Iy.01.040183.003221  1
1982 Beck BN, Frelinger JG, Shigeta M, Infante AJ, Cummings D, Hämmerling G, Fathman CG. T cell clones specific for hybrid I-A molecules. Discrimination with monoclonal anti-I-A(k) antibodies Journal of Experimental Medicine. 156: 1186-1194. PMID 6185607 DOI: 10.1084/Jem.156.4.1186  1
1981 Frelinger JG, Frelinger JA, Hood L. Peptide map comparisons of epidermal and spleen H-2 molecules Immunogenetics. 12: 569-577. PMID 7011955 DOI: 10.1007/Bf01561697  1
1981 Wettstein PJ, Frelinger JG, Hood L. Serological and biochemical characterization of rat (RT1) class II molecules with restricted mouse anti-Ia sera Immunogenetics. 13: 93-107. PMID 6971802 DOI: 10.1007/Bf00524607  1
1981 Steinmetz M, Moore KW, Frelinger JG, Sher BT, Shen FW, Boyse EA, Hood L. A pseudogene homologous to mouse transplantation antigens: transplantation antigens are encoded by eight exons that correlate with protein domains. Cell. 25: 683-92. PMID 6895187 DOI: 10.1016/0092-8674(81)90175-6  1
1981 Steinmetz M, Frelinger JG, Fisher D, Hunkapiller T, Pereira D, Weissman SM, Uehara H, Nathenson S, Hood L. Three cDNA clones encoding mouse transplantation antigens: Homology to immunoglobulin genes Cell. 24: 125-134. PMID 6786753 DOI: 10.1016/0092-8674(81)90508-0  1
1981 Steinmetz M, Frelinger JG, Fisher DA, Moore KW, Hood LE. Structural Studies Of Mouse Transplantation Antigen Genes Biochemical Society Transactions. 9. DOI: 10.1042/Bst009102Pa  1
1980 Frelinger JA, Frelinger JG. Bone marrow origin of Ia molecules purified from epidermal cells Journal of Investigative Dermatology. 75: 68-70. PMID 6967098 DOI: 10.1111/1523-1747.Ep12521247  1
1979 Frelinger JG, Hood L, Hill S, Frelinger JA. Mouse epidermal Ia molecules have a bone marrow origin [29] Nature. 282: 321-323. PMID 503207 DOI: 10.1038/282321A0  1
1978 Frelinger JG, Wettstein PJ, Frelinger JA, Hood L. Epidermal Ia molecules from the I-A and I-EC subregions of the mouse H-2 complex Immunogenetics. 6: 125-135. DOI: 10.1007/Bf01563903  1
1976 Frelinger JG, Motulsky H, Woodward DO. Effects of Chloramphenicol on the Circadian Rhythm of Neurospora crassa. Plant Physiology. 58: 592-4. PMID 16659724 DOI: 10.1104/Pp.58.4.592  0.01
Show low-probability matches.